Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies

Published:2023-02-01 Issue:1 Volume:6 Page:5-16
ISSN:2573-1599
Container-title:The CRISPR Journal
language:en
Short-container-title:The CRISPR Journal

Author:

Ureña-Bailén Guillermo¹^ORCID,Block Milena²,Grandi Tommaso²,Aivazidou Faidra²,Quednau Jona²,Krenz Dariusz²,Daniel-Moreno Alberto¹,Lamsfus-Calle Andrés¹,Epting Thomas³,Handgretinger Rupert¹⁴,Wild Stefan²^ORCID,Mezger Markus¹^ORCID

Affiliation:

1. Department of General Pediatrics, Oncology and Hematology, University Children's Hospital, Tübingen, Germany.

2. Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.

3. Institute for Clinical Chemistry and Laboratory Medicine, University Hospital, Freiburg, Germany.

4. Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Biotechnology

Link

https://www.liebertpub.com/doi/pdf/10.1089/crispr.2022.0086

Reference26 articles.

1. CRISPR to fix bad blood: a new tool in basic and clinical hematology

2. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection

3. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment

4. Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9

5. Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of exagamglogene autotemcel for the treatment of sickle cell disease and transfusion-dependent beta-thalassaemia;Expert Opinion on Biological Therapy;2024-09-02

2. Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells;Biomolecules;2024-08-14

3. Transcriptional regulators of fetal hemoglobin;Hematology, Transfusion and Cell Therapy;2024-08

4. Mobilization and collection of CD34 + cells in patients with globin disorders: Providing the starting material to manufacturers of autologous gene therapies;Transfusion and Apheresis Science;2024-06

5. Novel approaches for hematopoietic stem cell mobilisation and collection need to be assessed for qualification and validation to accomplish the proper requirements of their intended purpose;Transfusion and Apheresis Science;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3